Do aromatase inhibitors increase cardiovascular risk? Piecing together the evidence
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2016
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Aromatase (MeSH)
- Aromatase Inhibitors (MeSH)
- Breast Neoplasms (MeSH)
- Cardiovascular Diseases (MeSH)
- Enzyme Inhibitors (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Risk Factors (MeSH)
published in
- European Journal of Cancer Journal